179 related articles for article (PubMed ID: 8630296)
1. Epidemiology of in situ and invasive breast cancer in women aged under 45.
Weiss HA; Brinton LA; Brogan D; Coates RJ; Gammon MD; Malone KE; Schoenberg JB; Swanson CA
Br J Cancer; 1996 May; 73(10):1298-305. PubMed ID: 8630296
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age.
Evans WP; Starr AL; Bennos ES
Radiology; 1997 Aug; 204(2):489-91. PubMed ID: 9240541
[TBL] [Abstract][Full Text] [Related]
3. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
[TBL] [Abstract][Full Text] [Related]
4. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
[TBL] [Abstract][Full Text] [Related]
5. Ten-year follow-up of breast carcinoma in situ in Connecticut.
Ward BA; McKhann CF; Ravikumar TS
Arch Surg; 1992 Dec; 127(12):1392-5. PubMed ID: 1365682
[TBL] [Abstract][Full Text] [Related]
6. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
7. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.
Kerlikowske K; Barclay J; Grady D; Sickles EA; Ernster V
J Natl Cancer Inst; 1997 Jan; 89(1):76-82. PubMed ID: 8978410
[TBL] [Abstract][Full Text] [Related]
8. Trends of in situ carcinoma of the breast in Vaud, Switzerland.
Levi F; Te VC; Randimbison L; La Vecchia C
Eur J Cancer; 1997 May; 33(6):903-6. PubMed ID: 9291813
[TBL] [Abstract][Full Text] [Related]
9. Changing incidence rate of invasive lobular breast carcinoma among older women.
Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
[TBL] [Abstract][Full Text] [Related]
10. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
11. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.
Saltzstein SL
Anat Pathol; 1996; 1():193-203. PubMed ID: 9390929
[No Abstract] [Full Text] [Related]
12. Cancer statistics: Breast cancer in situ.
Ward EM; DeSantis CE; Lin CC; Kramer JL; Jemal A; Kohler B; Brawley OW; Gansler T
CA Cancer J Clin; 2015; 65(6):481-95. PubMed ID: 26431342
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.
Mullooly M; Khodr ZG; Dallal CM; Nyante SJ; Sherman ME; Falk R; Liao LM; Love J; Brinton LA; Gierach GL
Am J Epidemiol; 2017 Dec; 186(12):1329-1340. PubMed ID: 28637226
[TBL] [Abstract][Full Text] [Related]
14. Reduction mammaplasty specimens and occult breast carcinomas.
Kakagia D; Fragia K; Grekou A; Tsoutsos D
Eur J Surg Oncol; 2005 Feb; 31(1):19-21. PubMed ID: 15642421
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.
Vogel VG
Menopause; 2008; 15(4 Suppl):782-9. PubMed ID: 18596599
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking and risk of breast carcinoma in situ.
Trentham-Dietz A; Nichols HB; Egan KM; Titus-Ernstoff L; Hampton JM; Newcomb PA
Epidemiology; 2007 Sep; 18(5):629-38. PubMed ID: 17700252
[TBL] [Abstract][Full Text] [Related]
17. Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.
Rawal R; Lorenzo Bermejo J; Hemminki K
Br J Cancer; 2005 Jan; 92(1):162-6. PubMed ID: 15570309
[TBL] [Abstract][Full Text] [Related]
18. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland.
Verkooijen HM; Fioretta G; Vlastos G; Morabia A; Schubert H; Sappino AP; Pelte MF; Schäfer P; Kurtz J; Bouchardy C
Int J Cancer; 2003 May; 104(6):778-81. PubMed ID: 12640687
[TBL] [Abstract][Full Text] [Related]
19. Risk of contralateral breast cancer among women with carcinoma in situ of the breast.
Habel LA; Moe RE; Daling JR; Holte S; Rossing MA; Weiss NS
Ann Surg; 1997 Jan; 225(1):69-75. PubMed ID: 8998122
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for ductal and lobular breast cancer: results from the nurses' health study.
Kotsopoulos J; Chen WY; Gates MA; Tworoger SS; Hankinson SE; Rosner BA
Breast Cancer Res; 2010; 12(6):R106. PubMed ID: 21143857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
